[4] Inflammation & Healing

1. Fundamental Concepts of Inflammation

โ€˜์—ผ์ฆโ€™์ด๋ž€ ๋ฌด์—‡์ผ๊นŒ?

  • ์‚ด์•„์žˆ๊ณ  ํ˜ˆ๊ด€์ด ๋ถ„ํฌํ•œ ์กฐ์ง์—์„œ (occures within living, vascularized tissue)
  • ์†์ƒ์— ๋Œ€ํ•œ ๋ฐ˜์‘์œผ๋กœ ์ผ์–ด๋‚˜๋Š” (in response to injury)
  • ์ฒด์•ก๊ณผ ์„ธํฌ์ƒ์˜ ๋ณ€ํ™”์ด๋‹ค. (a well-organized cascade of fluidic and cellular changes)

๋‹ค์Œ์€ ์—ผ์ฆ์ด ์ƒ๊ฒผ์„ ๋•Œ ์ผ์–ด๋‚˜๋Š” ๋Œ€ํ‘œ์ ์ธ 5๊ฐ€์ง€ ์ง€ํ‘œ์ด๋‹ค.

  • Redness (Rubor)
  • Swelling (Tumor)
  • Heat (Calor)
  • Pain (Dolor)
  • Loss of function (Functio Laesa)

์ด๋Ÿฌํ•œ ์—ผ์ฆ ๋ฐ˜์‘์€ ์šฐ๋ฆฌ ๋ชธ์—์„œ ์†์ƒ์„ ์ผ์œผํ‚จ ์›์ธ์„ ํฌ์„์‹œํ‚ค๊ณ  ์ œ๊ฑฐํ•˜๊ธฐ ์œ„ํ•ด(dilute, isolate, eliminate) ์ผ์–ด๋‚˜๋Š” ๋ฐ˜์‘์ด๋‹ค.

๐ŸŸข Acute vs. Chronic Inflammation

์•ž์„œ ํ˜ˆ๊ด€ ๋‹จ์›์—์„œ ๋ฐฐ์šด ๊ฒƒ์ฒ˜๋Ÿผ, ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ๊ฐ€ ์ˆ˜์ถ•ํ•˜๋ฉด

  • ๋ถ„์ž ํฌ๊ธฐ๊ฐ€ ์ž‘์€ fluids ๊ฐ€ ๋จผ์ € ๋น ์ ธ๋‚˜๊ฐ€๊ณ ,
  • ์ ์  ๋” ๋งŽ์ด ์ˆ˜์ถ•ํ•ด์„œ ๊ณต๊ฐ„์ด ๋งŽ์ด ์ƒ๊ธฐ๋ฉด ๋‹จ๋ฐฑ์งˆ, ํ˜ˆ๊ตฌ์„ธํฌ ๋“ฑ์ด ๋‚˜๊ฐˆ ์ˆ˜ ์žˆ๋‹ค.

๊ทธ๋ž˜์„œ ๊ธ‰์„ฑ ์—ผ์ฆ ๋ฐ˜์‘์˜ ์ฒซ ๋ฒˆ์งธ ํŠน์ง•์€ โ€˜๋ถ€์ข…โ€™์ด๋‹ค.

AcuteChronic
Duration์ˆ˜ ์‹œ๊ฐ„ ~ ์ˆ˜ ์ผ์ˆ˜ ์ฃผ ~ ์ˆ˜ ๊ฐœ์›”, ์ˆ˜ ๋…„
Hallmark- Exudation of fluid and plasma proteins
: ์•ก์ฒด ์„ฑ๋ถ„, ๋‹จ๋ฐฑ์งˆ ์„ฑ๋ถ„์ด ๋จผ์ € ๊ธฐ์งˆ๋กœ(ํ˜ˆ๊ด€ ๋ฐ–์œผ๋กœ) ์ƒˆ์–ด๋‚˜์˜จ๋‹ค โ‡’ ๋ถ€์ข…
- Emigration of leukocytes, principally neutrophils
: ๋” ์ˆ˜์ถ•ํ•ด์„œ ๊ณต๊ฐ„์ด ๋„“์–ด์ง€๋ฉด ์—ผ์ฆ์„ธํฌ๊ฐ€ ๋™์›๋œ๋‹ค. (์ผ๋ฐ˜์ ์œผ๋กœ ํ˜ธ์ค‘๊ตฌ(neutrophils) ๊ฐ€ ์ฃผ๋กœ ์ฒ˜์Œ์— ๋™์›๋˜์ง€๋งŒ, ์›์ธ์— ๋”ฐ๋ผ ํ˜ธ์‚ฐ๊ตฌ๊ฐ€ ๋จผ์ € ๋™์›๋˜๊ธฐ๋„.)
- Fibrosis : ์„ฌ์œ ํ™” ์—ฌ๋ถ€๊ฐ€ ๊ฐ€์žฅ ์ค‘์š”ํ•œ ์ง€ํ‘œ.
- Presence of lymphocytes and macrophages
: ๋ฆผํ”„๊ตฌ๋Š” ๊ธ‰์„ฑ์—์„œ ๋งŒ์„ฑ ๋‹จ๊ณ„๋กœ ๋„˜์–ด๊ฐ€๋Š” ๋ฐ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•˜๋ฏ€๋กœ, ์ด๋ฏธ ๋งŒ์„ฑํ™”๋œ ๋ณ‘๋ณ€์—์„œ๋Š”๋งŽ์ด ์—†์„ ์ˆ˜๋„ ์žˆ๋‹ค.
Outcome
/Origin
์›์ธ์ด ํ•ด์†Œ๋˜๋ฉด ๊ธˆ๋ฐฉ ํšŒ๋ณต๋˜๊ณ  ์ข…๋ฃŒ.๊ธ‰์„ฑ ์—ผ์ฆ ๋ฐ˜์‘์˜ ๊ฒฐ๊ณผ or ์ง€์†์ ์ธ ์ž๊ทน์œผ๋กœ ์œ ๋ฐœ๋จ.

๐ŸŸข ๊ธ‰์„ฑ ์—ผ์ฆ ๋ฐ˜์‘์˜ overview

  • Fluidic (Exudative) Phase : ์ฒ˜์Œ์— fluid๊ฐ€ ๋‚˜์˜ค๊ณ 
  • Cellular Phase : ์„ธํฌ๊ฐ€ ๋™์›๋˜๋ฉฐ
  • Reparative Phase : ์›์ธ์ด ์ œ๊ฑฐ๋˜๊ณ  ํšŒ๋ณตํ•œ๋‹ค. (๋งŒ์„ฑ์œผ๋กœ ์ด์–ด์ง€์ง€ ์•Š๋Š”๋‹ค๋ฉด)

๐ŸŸข ์—ผ์ฆ์„ ์œ ๋ฐœํ•˜๋Š” ์›์ธ

์›์ธ์— ๋”ฐ๋ผ ๊ธ‰์„ฑ ๋˜๋Š” ๋งŒ์„ฑ ์—ผ์ฆ์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ์œผ๋‹ˆ, ๊ฐ๊ฐ์˜ ๋Œ€ํ‘œ์ ์ธ ์‚ฌ๋ก€๋ฅผ ์ค‘์š”ํ•˜๊ฒŒ ๋ณผ ํ•„์š”๊ฐ€ ์žˆ๋‹ค.

  • Microbes : ๊ฐ์—ผ์„ฑ ์›์ธ์ฒด (๋ฐ”์ด๋Ÿฌ์Šค, ์„ธ๊ท , ์›์ƒ๋™๋ฌผ, ๊ธฐ์ƒ์ถฉ)
  • Foreign bodies : ๋‚ด ๊ฒƒ์ด ์•„๋‹Œ ๋ชจ๋“  ๊ฒƒ. (ex. ์„ญ์ทจํ•œ ์ด๋ฌผ์ด ์†Œํ™”๊ธฐ๋ฅผ ๋šซ๊ณ  ๋‚˜๊ฐ. ๋˜์ƒˆ๊น€์งˆํ•œ ๋จน์ด(plant fibers ๋“ฑ) ๋น„๊ฐ•์œผ๋กœ ์ž˜๋ชป ํ–ฅํ•จ.)
  • Physical/Mechanical Actions
  • Chemicals (ํ™”ํ•™ ๋ฌผ์งˆ)

PAMPs์™€ DAMPs - ์—ผ์ฆ ๋ฐ˜์‘์„ ์œ ๋ฐœํ•˜๋Š” ๋‘ ๊ฐ€์ง€ ์ค‘์š”ํ•œ ๋ฌผ์งˆ์ด ์žˆ๋‹ค.

PAMPs
(Pathogen-Associated Molecular Patterns)
DAMPs
(Danger-Associated Molecular Patterns)
Microbes - ๊ฐ์—ผ์„ฑ ์›์ธ์ฒด๊ฐ€ ๋‚ด๋ฟœ๋Š” ๋ฌผ์งˆInjured host cells - ์†์ƒ๋œ ์ˆ™์ฃผ์„ธํฌ๊ฐ€ ๋ฐฉ์ถœํ•˜๋Š” ๋ฌผ์งˆ
(Necrosis์˜ ๊ฒฝ์šฐ์—๋งŒ. ๊ทธ๋ž˜์„œ necrosis๋Š” apoptosis์™€ ๋‹ฌ๋ฆฌ ์—ผ์ฆ์„ ์œ ๋ฐœํ•œ๋‹ค๋Š” ๊ฒƒ.)
LPS, peptidoglycan ๋“ฑHMGB1, uric acid ๋“ฑ
  • DAMPs๋Š” ์„ธํฌ ์†์ƒ์ด๋‚˜ ๊ดด์‚ฌ(necrosis) ์ƒํ™ฉ์—์„œ ๋ฐฉ์ถœ๋œ๋‹ค. Apoptosis๋Š” ๊ณ„ํš๋œ ์ฃฝ์Œ์ด๋ฏ€๋กœ ์ด๋Ÿฌํ•œ ๋ฌผ์งˆ์„ ๋ฐฉ์ถœํ•˜์ง€ ์•Š๋Š”๋‹ค. ๊ทธ๋ž˜์„œ necrosis์™€ apoptosis์˜ ๊ตฌ๋ถ„์ ์ด ์—ผ์ฆ ์œ ๋ฐœ ์œ ๋ฌด์ธ ๊ฒƒ.
  • PAMPs๋ฅผ ์ธ์‹ํ•˜๋Š” TLR์€ PRRs(Pattern Recognition Receptors)๋ผ๊ณ ๋„ ํ•˜๋Š”๋ฐ, ๋น„ํŠน์ด์  ํŒจํ„ด์„ ์ธ์‹ํ•œ๋‹ค. (์ฆ‰ ์„ ์ฒœ์„ฑ ๋ฉด์—ญ์˜ ๋‹ด๋‹น์ด๋‹ค.) ์ •ํ™•ํžˆ ์–ด๋–ค species์ธ์ง€๋Š” ๊ตฌ๋ถ„ํ•˜์ง€ ๋ชปํ•˜์ง€๋งŒ ์„ธ๊ท , ๋ฐ”์ด๋Ÿฌ์Šค ๋“ฑ ๊ฐ์—ผ์ฒด์˜ ์ข…๋ฅ˜์— ๋”ฐ๋ฅธ โ€˜ํŒจํ„ดโ€™์„ ์ธ์‹ํ•˜์—ฌ ์—ผ์ฆ ๋ฐ˜์‘์„ ์‹œ์ž‘ํ•œ๋‹ค.

2. Acute Inflammation (๊ธ‰์„ฑ ์—ผ์ฆ ๋ฐ˜์‘)

(1) Vascular & Fluidic Events

๐ŸŸข ์ดˆ๊ธฐ ํ˜ˆ๊ด€ ๋ฐ˜์‘ (Immediate Vascular Response)

  • Active Hyperemia : ์—ผ์ฆ ๋ฐ˜์‘์—์„œ ๊ฐ€์žฅ ๋จผ์ € ์ผ์–ด๋‚œ๋‹ค.
    • Hyperemia(์ถฉํ˜ˆ) : ํ˜ˆ๊ด€์ด ํ™•์žฅ๋œ active ์ƒํ™ฉ. (โ†” Congestion(์šธํ˜ˆ) : ํ˜ˆ์•ก์ด ์ •์ฒด๋œ passive ์ƒํ™ฉ)
  • Redness & Heat : ์ถฉํ˜ˆ์— ์˜ํ•ด ํ˜ˆ๋ฅ˜๋Ÿ‰์ด ๋Š˜์–ด๋‚ฌ๊ธฐ ๋•Œ๋ฌธ.
  • Slowing of Flow (Stasis) : ํ˜ˆ๋ฅ˜ ํ๋ฆ„์ด ๋А๋ ค์ง€๋ฉด์„œ ํ˜ˆ๊ตฌ ์„ธํฌ๋“ค์ด ๋ฐ–์œผ๋กœ ๋‚˜์˜ค๊ธฐ ์‰ฌ์›Œ์ง„๋‹ค.

๊ฒฐ๊ตญ ํ˜ˆ๊ด€ ํˆฌ๊ณผ์„ฑ์ด ์ฆ๊ฐ€๋œ๋‹ค๋Š” ์‚ฌ์‹ค์ด ์ค‘์š”ํ•˜๋‹ค!

๐ŸŸข ํ˜ˆ๊ด€ ํˆฌ๊ณผ์„ฑ ์ฆ๊ฐ€ (Increased Vascular Permeability)

Fluid leakage๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์€ mechanism์— ์˜ํ•ด ์ผ์–ด๋‚œ๋‹ค:

  • Endothelial Gap์˜ ํ˜•์„ฑ : ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ๊ฐ€ ์ˆ˜์ถ•ํ•˜๋ฉฐ gap ํ˜•์„ฑ.
    • ๊ฐ€์žฅ ํ”ํ•œ ๊ธฐ์ „. Histamine, bradykinin ๋“ฑ์˜ ์—ผ์ฆ๋งค๊ฐœ๋ฌผ์งˆ์ด ์ˆ˜์ถ•์„ ์œ ๋ฐœํ•œ๋‹ค. โ†’ fluid, ์„ธํฌ ์ˆœ์œผ๋กœ ๋น ์ ธ๋‚˜์˜จ๋‹ค.
  • Direct Endothelial Injury : ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ์˜ ์ง์ ‘์ ์ธ ์†์ƒ.
    • ํ˜ˆ๊ด€ํˆฌ๊ณผ์„ฑ์˜ ์ฆ๊ฐ€๊ฐ€ endothelium์˜ ์†์ƒ์„ ์ง์ ‘ ์œ ๋ฐœํ•˜์ง€๋Š” ์•Š์ง€๋งŒ, fluid๊ฐ€ ๋ฐฉ์ถœ๋˜๊ณ  ํ˜ˆ๋ฅ˜๊ฐ€ ์ •์ฒด๋˜๋ฉด์„œ ๋ถ€์ฐจ์ ์œผ๋กœ ์†์ƒ์ด ๋ฐœ์ƒํ•  ์ˆ˜ ์žˆ๋‹ค.
    • ๋˜ํ•œ ํ™”์ƒ(burns), ๋…์†Œ(certain toxins), ๊ฐ์—ผ(some infections)์— ์˜ํ•ด ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ๊ฐ€ ์†์ƒ๋œ๋‹ค.
  • Leukocyte-Dependent Injury : ๋ฐฑํ˜ˆ๊ตฌ์— ์˜ํ•œ ํ˜ˆ๊ด€๋ฒฝ ์†์ƒ.
    • ๋ฐฑํ˜ˆ๊ตฌ๊ฐ€ ๋™์›๋˜๋ฉด์„œ ROS(Reactive Oxygen Species)๋ผ๋Š” ์‚ฐํ™”์„ฑ ๋ฌผ์งˆ์„ ๋ถ„๋น„ํ•˜๋Š”๋ฐ, ์ด๊ฒƒ์ด ํ˜ˆ๊ด€๋ฒฝ์„ ์†์ƒ์‹œํ‚ฌ ์ˆ˜ ์žˆ๋‹ค.

์ฆ‰, ์—ผ์ฆ์ด ์ƒ๊ธด ์ด์œ ๊ฐ€ ๋”ฐ๋กœ ์žˆ๋”๋ผ๋„, ์—ผ์ฆ ๋ฐ˜์‘์œผ๋กœ ์ธํ•ด ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ์˜ ์†์ƒ์ด ์ง์ ‘์ ์œผ๋กœ ๋ฐœ์ƒํ•  ์ˆ˜ ์žˆ๋‹ค.

(Normal โ†’ ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ ์ˆ˜์ถ• โ†’ fluid ๋น ์ ธ๋‚˜๊ฐ โ†’ ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ ์†์ƒ โ†’ ๋ฐฑํ˜ˆ๊ตฌ์˜ transmigration์— ๋”ฐ๋ฅธ ํ˜ˆ๊ด€๋ฒฝ ์†์ƒ โ†’ ํ˜ˆ๊ตฌ์„ธํฌ๊นŒ์ง€ ๋น ์ ธ๋‚˜๊ฐ)

๐ŸŸข Transudate vs. Exudate

ํ˜ˆ๊ด€์˜ ์ข…๋ฅ˜์™€ ์‹œ๊ฐ„์˜ ํ๋ฆ„์— ๋”ฐ๋ผ, ๋ฌด์—‡์ด ํ˜ˆ๊ด€ ๋ฐ–์œผ๋กœ ๋น ์ ธ๋‚˜์˜ฌ์ง€๊ฐ€ ๋‹ค๋ฅด๋‹ค๋Š” ๊ฒƒ์„ ์•Œ์•„๋‘์ž.

๊ต์ˆ˜๋‹˜๋„ [ํ•œ๊ธ€ ์šฉ์–ด๋Š” ํ™•์‹คํ•˜์ง€ ์•Š์œผ๋‹ˆ ์ฐพ์•„๋ด๋ผ + ์˜์–ด๋กœ ์™ธ์šฐ์ž]๊ณ  ๋ง์”€ํ•˜์…จ๊ณ , ๋Œ€๋‹ค์ˆ˜์˜ ์ธํ„ฐ๋„ท ๊ฒฐ๊ณผ(+์ œ ํŒ๋‹จ)์œผ๋กœ๋Š” ๋ˆ„์ถœ/์‚ผ์ถœ์ด ๋งž๋Š” ๊ฒƒ ๊ฐ™์€๋ฐ ๋ฐ˜๋Œ€๋กœ ๋‚˜์˜ค๊ธฐ๋„ ํ•ฉ๋‹ˆ๋‹ค. ์˜์–ด ํ‘œํ˜„์ด ํ™•์‹คํ•˜๋‹ค..!

Transudate (๋ˆ„์ถœ์•ก)Exudate (์‚ผ์ถœ์•ก)
A fluid with minimal protein and low numbers of cells.An opaque, viscous fluid with high protein content and numerous leukocytes.
๋ง‘๋‹ค. (์ˆœ์ˆ˜ํ•œ ๋ฌผ)
ํ˜ˆ๊ตฌ ์„ธํฌ๋„ ์ ๋‹ค.
ํƒํ•˜๋‹ค.
๋‹จ๋ฐฑ์งˆ ์„ฑ๋ถ„๋„, ์„ฌ์œ ์†Œ๋„, ํ˜ˆ๊ตฌ์„ธํฌ๋„ ๋งŽ๋‹ค.
specific gravity < 1.012> 1.020
by ์ •์ˆ˜์••์˜ ์ฆ๊ฐ€ ๋˜๋Š” ์‚ผํˆฌ์••์˜ ๊ฐ์†Œby ์—ผ์ฆ ์ƒํ™ฉ์—์„œ ํ˜ˆ๊ด€ํˆฌ๊ณผ์„ฑ์˜ ์ฆ๊ฐ€
์ฃผ ์„ฑ๋ถ„์— ๋”ฐ๋ผ ๋ถ„๋ฅ˜๋œ๋‹ค.
- serous
- fibrinous
- suppurative
์—ผ์ฆ์„ฑ ๋ณ‘๋ณ€์˜ ํ˜•ํƒœํ•™์  ๋ช…๋ช…์— ์‚ฌ์šฉ๋จ.

๐ŸŸข The Role of Fibrin

  • Fibrinogen(์„ฌ์œ ์†Œ์›)์€ Exudate์˜ ํ˜•์„ฑ ๊ณผ์ •์—์„œ ํ˜ˆ๊ด€์—์„œ ์กฐ์ง์œผ๋กœ ๋‚˜์˜ค๋Š” ํ˜ˆ์žฅ ๋‹จ๋ฐฑ์งˆ๋กœ, ํ˜ˆ์•ก์„ ์—‰๊ธฐ๊ฒŒ ํ•œ๋‹ค.
  • ์กฐ์ง์œผ๋กœ ๋‚˜๊ฐ„ fibrinogen์€ ๋ชจ์—ฌ์„œ fibrin์„ ํ˜•์„ฑํ•œ๋‹ค. (polymerization)
  • Fibrin(์„ฌ์œ ์†Œ)์€ ์ƒ์ฒ˜ ๋ถ€์œ„์— ๊ทธ๋ฌผ๋ง ํ˜•ํƒœ๋กœ ํ˜•์„ฑ๋˜์–ด ์ถœํ˜ˆ์„ ๋ง‰๊ณ  ์ƒ์ฒ˜ ์น˜์œ ๋ฅผ ๋•๋Š” ๋‹จ๋ฐฑ์งˆ๋กœ, ์ฃผ์š” ๊ธฐ๋Šฅ์€ ๋‹ค์Œ๊ณผ ๊ฐ™๋‹ค.
    • (1) Containment : ์ž๊ทน์ด ํผ์ ธ๋‚˜๊ฐ€์ง€ ์•Š๋„๋ก ๊ตญ์†Œํ™”๋œ ์˜์—ญ์— ๊ฐ€๋‘”๋‹ค.
    • (2) Leukocyte target : ๋ฐฑํ˜ˆ๊ตฌ์—๊ฒŒ ๋ถ„๋ช…ํ•œ ํ‘œ์ ์„ ์ œ๊ณตํ•œ๋‹ค. (์„ฌ์œ ์†Œ๊ฐ€ ์นจ์ฐฉ๋˜๋ฉด ํ˜ˆ๊ตฌ์„ธํฌ๊ฐ€ ๋” ๋‹ฌ๋ผ๋ถ™๊ธฐ ์‰ฌ์›Œ์ง„๋‹ค.)
    • (3) Scaffold for healing : ์กฐ์ง ์žฌ์ƒ์„ ๋•๋Š”๋‹ค.
      (์„ฌ์œ ์•„์„ธํฌ์™€ ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ๊ฐ€ ์ด๋™ํ•  ์ง€์ง€ ๊ตฌ์กฐ๋ฅผ ํ˜•์„ฑํ•œ๋‹ค. - ์„ฌ์œ ์•„์„ธํฌ(fibroblast)๋Š” ์ฝœ๋ผ๊ฒ์„ ์ƒ์„ฑํ•˜์—ฌ ์กฐ์ง์„ ๋ณต๊ตฌํ•˜๊ณ , ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ(endothelium)๋Š” ์‹ ์ƒ ํ˜ˆ๊ด€์„ ํ˜•์„ฑ)

ํ•˜์ง€๋งŒ ์„ฌ์œ ์†Œ๊ฐ€ ๊ณผ๋„ํ•˜๊ฒŒ ์ƒ์„ฑ๋˜๋ฉด ํ‰๋ง‰ ํŽ˜๋ ด, ์œ ์„ ์—ผ ๋“ฑ์—์„œ ์ด๋ ‡๊ฒŒ ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ๋‹ค.

(2) Cellular Events

๐ŸŸข Leukocyte Adhesion Cascade

์ฒ˜์Œ์— ์—ผ์ฆ์ด ์ƒ๊ธฐ๋ฉด fluid์™€ ์ €๋ถ„์ž์„ฑ ๋‹จ๋ฐฑ์งˆ(fibrin ๋“ฑ)์ด ๋‚˜์˜ค๊ณ , ๊ทธ ๋‹ค์Œ์—๋Š” ์—ผ์ฆ์„ธํฌ๋“ค๋„ ํ˜ˆ๊ด€ ๋ฐ–์œผ๋กœ ๋‚˜์˜จ๋‹ค. (ํ˜ˆ๊ตฌ์„ธํฌ๊ฐ€ ๊ตฌ๋ฅด๋‹ค๊ฐ€ ๋‹ฌ๋ผ๋ถ™๊ณ  โ†’ ๋” ๋งŽ์ด ํ™•์žฅ์‹œํ‚ค๊ณ  โ†’ ๋” ๋งŽ์ด ๋‚˜์˜ค๋Š” ์‹์œผ๋กœ ์ง„ํ–‰๋œ๋‹ค.)
๋ฐฑํ˜ˆ๊ตฌ๊ฐ€ ํ˜ˆ๊ด€ ๋‚ด๊ฐ•์—์„œ ์ƒ์ฒ˜ ๋ถ€์œ„๋กœ ์ด๋™ํ•˜๋Š” ์ˆœ์ฐจ์ ์ธ ๊ณผ์ •(cascade)์€ 4 step์œผ๋กœ ์ง„ํ–‰๋˜๋ฉฐ, ๊ฐ๊ฐ์˜ ๋‹จ๊ณ„์—์„œ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•˜๋Š” ๋‹จ๋ฐฑ์งˆ์ด ๋‹ค๋ฅด๋‹ค.

  1. Migration : ํ˜ˆ๋ฅ˜๊ฐ€ ๋А๋ ค์ง€๋ฉด์„œ ํ˜ˆ๊ด€๋ฒฝ ์ชฝ์œผ๋กœ ์ด๋™ํ•˜๊ณ ,
  2. Rolling : ๋ฐ๊ตด๋ฐ๊ตด ๊ตฌ๋ฅด๋ฉด์„œ ์†๋„๋ฅผ ๋Šฆ์ถ˜๋‹ค.
  3. Stable Adhesion : ์•ˆ์ •์ ์œผ๋กœ ์ž๋ฆฌ๋ฅผ ์žก๊ณ  ๊ฒฐํ•ฉํ•˜๋ฉด,
  4. Transmigration : ํ˜ˆ๊ด€๋ฒฝ์„ ๋šซ๊ณ  ์กฐ์ง์œผ๋กœ ๋‚˜์˜จ๋‹ค.

ํ˜ˆ๊ตฌ์„ธํฌ์˜ ์›๋ž˜ ์†๋„๋Œ€๋กœ๋Š” ๋„ˆ๋ฌด ๋นจ๋ผ์„œ ์ ˆ๋Œ€ ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ ์‚ฌ์ด๋กœ ๋‚˜์˜ฌ ์ˆ˜ ์—†๋‹ค!
Selectin ์˜ ๊ฒฐํ•ฉ์œผ๋กœ ์†๋„๋ฅผ ๋Šฆ์ถ”๊ณ  (๋ธŒ๋ ˆ์ดํฌ ์‚ด์ง์”ฉ ๋ฐŸ์Œ), integrin์˜ ๊ฒฐํ•ฉ์œผ๋กœ ์™„์ „ํžˆ ๋‹ฌ๋ผ๋ถ™์œผ๋ฉด (๋ธŒ๋ ˆ์ดํฌ๋ฅผ ๊ฝ‰ ๋ฐŸ์Œ) โ†’ ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ ์‚ฌ์ด๋กœ ๋‚˜๊ฐˆ ์ˆ˜ ์žˆ๊ฒŒ ๋˜๋Š” ๊ฒƒ.


1๏ธโƒฃ Rolling (Selectin์˜ ๊ฒฐํ•ฉ)

selectin์€ ์•„์ฃผ ์•ฝํ•œ, ์ดˆ๋ฐ˜์˜ ๊ฒฐํ•ฉ์„ ๋งŒ๋“œ๋Š” ๋‹จ๋ฐฑ์งˆ์ด๋‹ค.

  • L-selectin : Leukocytes์— ์žˆ์Œ
  • E-selectin : Endothelial cell์— ์žˆ์Œ
  • P-selectin : endothelial cell + Platelet์— ์žˆ์Œ

Selectin ๊ฐ„์˜ ๊ฒฐํ•ฉ์€ ์†๋„๋ฅผ ๋Šฆ์ถ”๋Š” ์—ญํ• ์„ ํ•œ๋‹ค. (Selectin์€ Sialyl Lewis X ๋ผ๋Š” ligand์— ๊ฒฐํ•ฉํ•œ๋‹ค; ์ด๊ฒƒ๊นŒ์ง€ ์•Œ ํ•„์š”๋Š” ์—†๋‹ค)

์ด๋•Œ selectin๊ณผ integrin์˜ ๊ฒฐํ•ฉ์ด ๋™์‹œ์— ์ด๋ฃจ์–ด์ง€์ง€๋Š” ์•Š๋Š”๋‹ค. (๋ธŒ๋ ˆ์ดํฌ๋ฅผ ์‚ด์‚ด ๋ฐŸ๋Š” ๋™์‹œ์— ๊ธ‰๋ธŒ๋ ˆ์ดํฌ๊ฐ€ ๊ฑธ๋ฆฌ๋ฉด ์•ˆ ๋˜๋‹ˆ๊นŒ..)
selectin ๊ฐ„์˜ ๊ฒฐํ•ฉ์ด ์ด๋ฃจ์–ด์ง€๋Š” ์ˆœ๊ฐ„์— integrin์€ ์‚ฌ์‹ค์ƒ ๋น„ํ™œ์„ฑํ™” ์ƒํƒœ. (โ†’ ์ด๋ฅผ โ€˜low-affinity stateโ€™๋ผ๊ณ  ํ•œ๋‹ค.)

2๏ธโƒฃ Stable adhesion (Integrin์˜ ๊ฒฐํ•ฉ)

Integrin์€ ๋งค์šฐ ๋‹จ๋‹จํ•œ, ์ตœ์ข… ๊ฒฐํ•ฉ์„ ๋งŒ๋“ ๋‹ค.

  • ํ‰์†Œ์—๋Š” low-affinity ์ƒํƒœ๋กœ ์กด์žฌํ•˜์ง€๋งŒ
  • Chemokine์— ์˜ํ•ด ํ™œ์„ฑํ™”๋˜๋ฉด, ํ‘œ๋ฉด ๋‹จ๋ฐฑ์งˆ ๊ตฌ์กฐ๊ฐ€ ๋ฐ”๋€Œ๋ฉด์„œ high-affinity ์ƒํƒœ๊ฐ€ ๋œ๋‹ค.
  • ํ™œ์„ฑํ™”๋œ ํ˜ˆ๊ตฌ์„ธํฌ์˜ integrin์ด ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ์˜ ํ‘œ๋ฉด ๋‹จ๋ฐฑ์งˆ(ICAM-1)๊ณผ ๋‹จ๋‹จํ•œ ๊ฒฐํ•ฉ์„ ํ˜•์„ฑํ•œ๋‹ค.

3๏ธโƒฃ Transmigration

(1) ๋ถ€์ฐฉ๋œ ํ˜ˆ๊ตฌ์„ธํฌ๋Š” ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜์—ฌ intracellular junction์„ ํ†ต๊ณผํ•œ๋‹ค. ์ด๋•Œ ์ž‘์šฉํ•˜๋Š” ์ฃผ์š” ๋ถ„์ž(์ ‘์ฐฉ ๋‹จ๋ฐฑ์งˆ)๋กœ๋Š”..

  • PECAM-1 (CD31) : ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ์ธ์ง€ ์•„๋‹Œ์ง€ ํ™•์ธํ•˜๋Š” ์—ญํ• . (ICAM-1, PECAM-1, CD18, integrin ๋“ฑ ํ‘œ๋ฉด ๋‹จ๋ฐฑ์งˆ๋“ค์€ ํŠน์ • ์„ธํฌ์—์„œ๋งŒ ๋ฐœํ˜„๋˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์•„์„œ, ํŠน์ • ์„ธํฌ๋ฅผ ๋ฐํ˜€๋‚ด๊ธฐ ์œ„ํ•œ ๋ฉด์—ญ ์—ผ์ƒ‰์˜ marker๋กœ์„œ๋„ ์“ฐ์ธ๋‹ค. PECAM-1๋„ ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ๋ฅผ ํ™•์ธํ•˜๋Š” ๋‹จ๋ฐฑ์งˆ ๋งˆ์ปค๋กœ ์“ฐ์ž„.)
  • ๊ทธ๋ฆฌ๊ณ  JAMs (Junctional Adhesion Molecules) ๋“ฑ์ด ์žˆ๋‹ค. (์„ค๋ช…ํ•˜์ง€ ์•Š์Œ)

(2) ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ๋Š” retraction์œผ๋กœ ๊ตฌ๋ฉ์„ ๋‚ด์ง€๋งŒ, ๊ธฐ์ €๋ง‰์€ ๊ทธ๋ ‡์ง€ ์•Š๊ธฐ ๋•Œ๋ฌธ์—
ํ˜ˆ๊ด€ ๋‚ด์—์„œ ์กฐ์ง์œผ๋กœ ์ด๋™ํ•  ๋•Œ basement membrane์„ ๋Š์–ด์•ผ ํ•œ๋‹ค.

  • ๋ฐฑํ˜ˆ๊ตฌ์—์„œ ๋ถ„๋น„๋˜๋Š” collagenase ๋“ฑ์˜ ํšจ์†Œ๊ฐ€ ์ฝœ๋ผ๊ฒ์„ ๋ถ„ํ•ดํ•œ๋‹ค. (*cf) basement membrane์˜ Lamina densa, Lamina reticularis ์ธต์ด ์ฝœ๋ผ๊ฒ์œผ๋กœ ๊ตฌ์„ฑ๋จ)

์กฐ์ง์œผ๋กœ ๋‚˜๊ฐ€๋ฉด fibrin & fibronectin ๋“ฑ์ด ๋ฐฑํ˜ˆ๊ตฌ๋ฅผ ๋ถ™์žก์•„์ค€๋‹ค.

๋ชจ์‹๋„์™€ ์‹ค์ œ ์กฐ์ง ์‚ฌ์ง„์„ ์ž˜ ์—ฐ๊ฒฐ์‹œ์ผœ ๊ธฐ์–ตํ•˜๊ธฐ ๋ฐ”๋žŒ!


๐ŸŸข Effector Cells (์—ผ์ฆ ๋ฐ˜์‘์„ ์ˆ˜ํ–‰ํ•˜๋Š” ํ•ต์‹ฌ ์„ธํฌ๋“ค)

์—ผ์ฆ์˜ ์ง„๋‹จ๋ช…(suppurative, fibrinous, granulomatous)์„ ๋ถ™์ผ ๋•Œ ์–ด๋–ค ์—ผ์ฆ์„ธํฌ๊ฐ€ ๋งŽ์ด ๋™์›๋˜์–ด ์žˆ๋Š”์ง€๋ฅผ ์ค‘์š”ํ•˜๊ฒŒ ๋ณธ๋‹ค. ๊ทธ๋ž˜์„œ ์—ผ์ฆ์„ธํฌ๊ฐ€ ์กฐ์ง์ƒ์—์„œ ์–ด๋–ป๊ฒŒ ๊ด€์ฐฐ๋˜๋Š”์ง€ ์ž˜ ์•Œ์•„์•ผ ํ•œ๋‹ค.

โš™๏ธ Neutrophils (ํ˜ธ์ค‘๊ตฌ)

์ด๋ฌผ, ๊ฐ์—ผ, ์–ด๋–ค ๋ฐ˜์‘์ด๋“  ๊ฐ€์žฅ ๋จผ์ € ๋™์›๋˜๋Š” ๊ฒƒ์ด ํ˜ธ์ค‘๊ตฌ! (๋ฐœ์ƒ 6-24์‹œ๊ฐ„ ์ด๋‚ด ๋„์ฐฉ)

  • Phagocytosis (์‹๊ท  ์ž‘์šฉ) : ๋ฏธ์ƒ๋ฌผ, ์ด๋ฌผ ๋“ฑ์„ ์ œ๊ฑฐํ•œ๋‹ค.
    (๊ธฐ์กด์—๋Š” granule์„ ๋ถ„๋น„ํ•ด ์›์ธ์ฒด๋ฅผ ์ฃฝ์ด๋Š” ๊ฒƒ๋งŒ ์ƒ๊ฐํ–ˆ๋Š”๋ฐ, ํ˜ธ์ค‘๊ตฌ๋„ ๋Œ€์‹์„ธํฌ์ฒ˜๋Ÿผ ํƒ์‹ ์ž‘์šฉ์„ ํ•˜๊ธด ํ•œ๋‹ค!)
  • Killing & Degradation (ํšจ์†Œ ๋ถ„๋น„) : ๋ณ‘์›์ฒด๋ฅผ ์ œ๊ฑฐํ•˜๊ธฐ ์œ„ํ•œ ๋ฌผ์งˆ์„ ๋ฐฉ์ถœํ•œ๋‹ค.
  • NET formation (NET ํ˜•์„ฑ) : apoptosis๋กœ ์ฃฝ์œผ๋ฉด์„œ ๊ทธ๋ฌผ๋ง ๊ฐ™์€ ๊ตฌ์กฐ๋ฅผ ๋งŒ๋“ค์–ด๋‚ด๋Š”๋ฐ, ์ด NETs(Neutrophil Extracellular Traps) ๊ตฌ์กฐ๊ฐ€ ๋ฐ•ํ…Œ๋ฆฌ์•„๋ฅผ ํฌํšํ•˜๊ณ  ์ฃฝ์ธ๋‹ค.

* Pus Formation (๋† ํ˜•์„ฑ)

  • ์›์ธ์ฒด๊ฐ€ ์ด๊ฑธ๋กœ ์ œ๊ฑฐ๋˜์ง€ ๋ชปํ•˜๋ฉด, pus(๋†)์ด ์ƒ๊ธด๋‹ค:
    neutrophils + ์ฃฝ์€ ์„ธํฌ ๋ฉ์–ด๋ฆฌ + edema fluid ๋“ฑ์˜ ์ถ•์ ์œผ๋กœ ๋งŒ๋“ค์–ด์ง„ ๋ˆ„๋ ‡๊ณ  ์ง„๋“ํ•œ ๋ฉ์–ด๋ฆฌ.
โš™๏ธ Macrophages (๋Œ€์‹์„ธํฌ)

๋‹จํ•ต๊ตฌ์—์„œ ์œ ๋ž˜๋œ ์„ธํฌ๋กœ, ํ˜ˆ๊ด€์—์„œ๋Š” ๊ฑฐ์˜ ๋ฐœ๊ฒฌํ•  ์ˆ˜ ์—†๋‹ค. ํ˜ˆ๊ด€์„ ๋Œ์•„๋‹ค๋‹ˆ๋˜ ๋‹จํ•ต๊ตฌ(blood monocyte)๊ฐ€ ์กฐ์ง์— ๋™์›๋œ ํ›„ ๋ถ„ํ™”๋œ ๊ฒƒ์ด macrophage.
(๋ฐœ์ƒ 12-48์‹œ๊ฐ„ ํ›„ ๋„์ฐฉ / 24-48์‹œ๊ฐ„ ๋’ค์—๋Š” predominant cell์ด ๋จ. : macrophage๋„ ์ดˆ๋ฐ˜์— ๋น ๋ฅด๊ฒŒ ๋™์›๋˜๋Š” ํŽธ โ†’ ์ด๊ฑธ๋กœ ๋งŒ์„ฑ, ๊ธ‰์„ฑ์„ ํŒ๋‹จํ•˜๊ธฐ๋Š” ์• ๋งคํ•จ. ๊ทธ๋ž˜์„œ ๋งŒ์„ฑ ์—ผ์ฆ์˜ ์ค‘์š”ํ•œ ์ง€ํ‘œ๋Š” macrophage๋ณด๋‹ค fibrosis๊ฐ€ ๋จ.)

  • Phagocytosis (ํƒ์‹ ์ž‘์šฉ) : ์ฃฝ์€ neutrophils๋‚˜ ์ฃฝ์€ ์„ธํฌ, ๊ดด์‚ฌ๋œ ์กฐ์ง debris ๋“ฑ์„ ๋จน์–ด์„œ ์—†์•ค๋‹ค.
  • Antigen Presentation (ํ•ญ์› ์ œ์‹œ) : ๋จน๊ณ  ๋๋‚˜๋Š” ๊ฒŒ ์•„๋‹ˆ๋ผ ๋‹ค์Œ ๊ณผ์ •์œผ๋กœ ์ง„ํ–‰ํ•˜๋Š” ์‹ ํ˜ธ๋ฅผ ๋ณด๋‚ธ๋‹ค! ๋ณ‘์›์ฒด๋ฅผ ํฌ์‹ํ•˜๊ณ  ๊ทธ ๋ณ‘์›์ฒด์˜ ํ•ญ์›์„ ๋…ธ์ถœ์‹œ์ผœ T๋ฆผํ”„๊ตฌ๊ฐ€ ์ธ์‹ํ•˜๊ฒŒ ํ•œ๋‹ค. (APC)
  • Initiation of Repair (์กฐ์ง ํšŒ๋ณต ์‹ ํ˜ธ) : ์กฐ์ง์€ ์„ฌ์œ ํ™”(fibrosis)๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ์ฃฝ์€ ์„ธํฌ์˜ ์žฌ์ƒ์ด ์ด๋ฃจ์–ด์ง„๋‹ค. ๋Œ€์‹์„ธํฌ๋Š” fibroblast๋ฅผ ์ฆ์‹์‹œํ‚ค๊ณ  ํ˜ˆ๊ด€์„ ๋งŒ๋“ค ์ˆ˜ ์žˆ๋Š” ์„ฑ์žฅ ์ธ์ž(PDGF, TGF-ฮฒ ๋“ฑ)๋ฅผ ๋ถ„๋น„ํ•œ๋‹ค.
  • Centrol Role in Chronic Inflammation (๋งŒ์„ฑ ์—ผ์ฆ์˜ ์ค‘์‹ฌ ์—ญํ• ) : ์ž๊ทน์ด ์ง€์†๋˜๊ฑฐ๋‚˜, ๊ธ‰์„ฑ ์—ผ์ฆ์œผ๋กœ ์ œ๊ฑฐํ•  ์ˆ˜ ์—†๋Š” ๋ณ‘์›์ฒด๋Š” ๋งŒ์„ฑ ์—ผ์ฆ์—์„œ ์ œ๊ฑฐ.
โš™๏ธ Mast Cells (๋น„๋งŒ์„ธํฌ)

์ •์ƒ ์ƒํ™ฉ์—๋„ ํ•ญ์ƒ ์กด์žฌํ•˜๋ฉฐ, ์ผ๋ฐ˜์ ์œผ๋กœ ์ž‘์€ ํ˜ˆ๊ด€ ์ฃผ๋ณ€์— ์กด์žฌํ•œ๋‹ค. (ํ˜ˆ๊ด€ ์ด์™„, ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ ์ˆ˜์ถ• ๋“ฑ์˜ ์ƒํ™ฉ์—์„œ ๋น ๋ฅด๊ฒŒ ๋Œ€์‘ํ•˜๊ธฐ ์œ„ํ•ด)
๋ณดํ†ต eosinophils์™€ ๊ฐ™์ด ์›€์ง์ธ๋‹ค. * Mast cell tumor(MCT) : MCT๋Š” ํ˜ธ์‚ฐ๊ตฌ๋ฅผ ๋งค์šฐ ๋งŽ์ด ๋ถˆ๋Ÿฌ๋“ค์ด๋Š” ๊ฒฝํ–ฅ์ด ์žˆ๋‹ค. ์กฐ์งํ•™์ ์œผ๋กœ MCT๋ฅผ ํŒ๋‹จํ•˜๊ธฐ ์–ด๋ ค์šธ ๋•Œ, eosinophil์ด ๋งŽ์œผ๋ฉด mast cell ์œ ๋ž˜๋ผ๊ณ  ์ถ”์ธกํ•  ์ˆ˜ ์žˆ์„ ์ •๋„.

  • โ€œsentinels(๋ณด์ดˆ)โ€œ๋กœ์„œ ๊ฐ€์žฅ ๋จผ์ € ๋Œ€์‘ํ•˜๊ณ  ์ดˆ๊ธฐ ์—ผ์ฆ ๋ฐ˜์‘์„ ์œ ๋„ํ•œ๋‹ค.
    (* sentinel cell : ๋ณ‘์›์ฒด์˜ ์นจ์ž…์„ ๊ฐ€์žฅ ๋จผ์ € ์ธ์‹ํ•˜๊ณ  ์‹ ํ˜ธ๋ฅผ ๋ณด๋‚ด๋Š” ์„ธํฌ. ๋Œ€ํ‘œ์ ์œผ๋กœ macrophages, dendritic cells, mast cells.)
  • histamine ๋“ฑ ์—ผ์ฆ๋งค๊ฐœ๋ฌผ์งˆ์„ ๋น ๋ฅด๊ฒŒ ๋ถ„๋น„ํ•œ๋‹ค.
โš™๏ธ Eosinophils (ํ˜ธ์‚ฐ๊ตฌ)

์•Œ๋Ÿฌ์ง€ ๋ฐ˜์‘์ด ์žˆ์„ ๋•Œ, ๊ธฐ์ƒ์ถฉ ๊ฐ์—ผ์ด ์žˆ์„ ๋•Œ ํŠน์ด์ ์œผ๋กœ ๋งŽ์ด ๊ด€์ฐฐ๋œ๋‹คโ—

  • ๊ธฐ์ƒ์ถฉ ๊ฐ์—ผ ์‹œ ๋‚ด๋ฟœ๋Š” MBP(Major Basic Protein) ๊ฐ€ ๊ธฐ์ƒ์ถฉ์— ๋งค์šฐ ํšจ๊ณผ์ (toxic to parasites).
  • MBP๋Š” tissue damage๋ฅผ ์œ ๋ฐœํ•  ์ˆ˜๋„ ์žˆ๋‹ค.
๐Ÿ–ผ๏ธ ๋ชจ์‹๋„

๐Ÿ”ฌ ์กฐ์ง ๊ด€์ฐฐ ์‚ฌ์ง„

๐ŸŸข Other Key Cells

โš™๏ธ Lymphocytes
  • ํ›„์ฒœ์„ฑ ๋ฉด์—ญ์— ํ•„์ˆ˜์ ์ธ ์—ญํ• ์„ ํ•œ๋‹ค. (ํ•ญ์› ์ œ์‹œ ๋ฐ ์„ธํฌ์„ฑ ๋ฉด์—ญ/์ฒด์•ก์„ฑ ๋ฉด์—ญ ์ฃผ๋„)
  • ๊ธ‰์„ฑ ์—ผ์ฆ์—์„œ ๋จผ์„ฑ ์—ผ์ฆ ๋ฐ˜์‘์œผ๋กœ ๋„˜์–ด๊ฐˆ ๋•Œ ๊ฐ€์žฅ ์ค‘์š”ํ•œ ์—ญํ• . (24-48์‹œ๊ฐ„ ์ •๋„ ์ง€๋‚œ ๋’ค ๋™์›๋จ)
โš™๏ธ Basophils

ํฌ์œ ๋ฅ˜์—์„œ ์ž˜ ๋ณผ ์ผ๋„ ์—†๊ณ , ์ค‘์š”ํ•˜์ง€ ์•Š๋‹ค.

  • IgE receptor๋ฅผ ๊ฐ€์ง€๊ณ , ํ˜ˆ๊ด€ ์†์„ ๋Œ์•„๋‹ค๋‹Œ๋‹ค.
  • histamine, cytokine (IL-4, IL-13) ๊ฐ™์€ ๋งค๊ฐœ๋ฌผ์งˆ์„ ๋ถ„๋น„ํ•œ๋‹ค.
  • ์•Œ๋Ÿฌ์ง€ ๋ฐ˜์‘(Th2-type)์— ๊ธฐ์—ฌํ•œ๋‹ค.
โš™๏ธ Endothelial Cells

๋‹จ์ˆœํ•œ barrier๊ฐ€ ์•„๋‹Œ, ์—ผ์ฆ ๋ฐ˜์‘์˜ ์ ๊ทน์ ์ธ ์กฐ์ ˆ์ž๋กœ์„œ ์—ญํ• ํ•œ๋‹ค.

  • Regulate vascular tone : ํ˜ˆ๋ฅ˜๋Ÿ‰๊ณผ ํ˜ˆ๊ด€ ํ™•์žฅ ์กฐ์ ˆ
  • Adhesion molecules : ๋ฐฑํ˜ˆ๊ตฌ๊ฐ€ ํ˜ˆ๊ด€๋ฒฝ์— ๋ถ™์„ ์ˆ˜ ์žˆ๋Š” ์ ‘์ฐฉ ๋ถ„์ž ๋ฐœํ˜„
  • Inflammatory mediators : cytokines, chemokines ๋“ฑ ์—ผ์ฆ๋งค๊ฐœ๋ฌผ์งˆ ๋ถ„๋น„

3. Chemical Mediators of Inflammation

๊ทธ๋ฆฌ ์ค‘์š”ํ•˜๊ฒŒ ์„ค๋ช… ์•ˆ ํ•˜์…”์„œ ์ข€ ๋‚˜์ค‘์— ์ •๋ฆฌํ•˜๊ฒ ์Šต๋‹ˆ๋‹ค..

4. Chronic Inflammation (๋งŒ์„ฑ ์—ผ์ฆ ๋ฐ˜์‘)

๊ธ‰์„ฑ ์—ผ์ฆ ๋ฐ˜์‘์€ ํ˜ˆ๊ด€ ํˆฌ๊ณผ์„ฑ์ด ์ฆ๊ฐ€ํ•˜๋ฉฐ ์—ผ์ฆ์„ธํฌ๋“ค์ด ํ˜ˆ๊ตฌ ๋ฐ–์œผ๋กœ ๋‚˜์˜ค๋Š” ์‹์œผ๋กœ ์‹œ์ž‘๋œ๋‹ค. ๊ทธ๊ฒƒ์œผ๋กœ ์ž๊ทน์ด ํ•ด๊ฒฐ๋˜์ง€ ์•Š์œผ๋ฉด โ€˜๋งŒ์„ฑํ™”โ€™๋œ๋‹ค.

  • ํŠน์ • ๋ณ‘์›์ฒด์˜ ๊ฒฝ์šฐ ๋งŒ์„ฑํ™”๊ฐ€ ๋น ๋ฅด๊ฒŒ ์ง„ํ–‰๋˜๊ธฐ๋„ ํ•œ๋‹ค.

โ€˜๋งŒ์„ฑโ€™์ด๋ผ ํ•จ์€ ๋ฐ˜์‘์ด ์ˆ˜ ์ฃผ ~ ์ˆ˜ ๊ฐœ์›” ๋‹จ์œ„๋กœ ๋Š˜์–ด๋‚œ๋‹ค.

neutrophils : ๊ธ‰์„ฑ ์—ผ์ฆ ๋ฐ˜์‘์˜ key ๋งŒ์„ฑ ์—ผ์ฆ ๋‹จ๊ณ„๋กœ ๋„˜์–ด๊ฐ€๋ฉด,

  • lymphocytes
  • ๋งŽ์€ ์ข…๋ฅ˜์˜ ๋Œ€์‹์„ธํฌ
  • ์„ฌ์œ ํ™” (fibrosis)

๐ŸŸข Causes

  • Mycobacterium spp., ๊ณฐํŒก์ด(fungi), ๊ธฐ์ƒ์ถฉ(parasites)

    • Coccidiosisโ€ฆ
  • ๋†์–‘(abscess)์— โ€œhidingโ€ ํ•˜๋Š” ์„ธ๊ท ๋“ค์ด ์žˆ๋‹ค.

    • ๋†์–‘์€ ์„ฌ์œ ์†Œ์„ฑ ๊ฒฐํ•ฉ์กฐ์ง์œผ๋กœ ์™„์ „ํžˆ ๋‘˜๋Ÿฌ์‹ธ์—ฌ ์žˆ์Œ โ†’ ์„ธ๊ท ์„ ์ฃฝ์ด๊ธฐ ์œ„ํ•ด ํ•ญ์ƒ์ œ๋ฅผ ์จ๋„, ํ•ญ์ƒ์ œ๊ฐ€ ๋šซ๊ณ  ๋“ค์–ด๊ฐ€์ง€ ๋ชปํ•จ. ๋ฉด์—ญ ๋ฐ˜์‘์ด๋‚˜ ์•ฝ์ œ๋กœ ํ•ด๊ฒฐ๋˜์ง€ ์•Š์•„ ๋งŒ์„ฑ์œผ๋กœ ์ด์–ด์ง.
  • ์ด๋ฌผ : ๋ฉด์—ญ์„ธํฌ๊ฐ€ ๊ฐ€์ง„ ํšจ์†Œ๋กœ ๋ถ„ํ•ด๋˜์ง€ ์•Š์•„ ๋งŒ์„ฑ ์—ผ์ฆ ๋ฐ˜์‘์„ ์œ ๋ฐœํ•œ๋‹ค.

    • ๋งŒ์„ฑ์ด ๊ผญ ๋‚˜์œ ๊ฒƒ์ด ์•„๋‹˜. ์ „์‹ ์œผ๋กœ ํผ์ ธ๊ฐ€์ง€ ์•Š๋„๋ก ์šฐ๋ฆฌ ๋ชธ์ด ๋ง‰๊ณ  ์žˆ๋Š” ๊ฒƒ.
  • ์ž๊ฐ€๋ฉด์—ญ์งˆํ™˜ : antigen์„ ์ธ์‹ํ•˜๊ณ  ๊ณต๊ฒฉํ•˜๋Š” ๊ณผ์ •์ด ๋งŒ์„ฑ ๋‹จ๊ณ„๊นŒ์ง€ ์ด์–ด์ง.

  • Leukocyte defects : ๋ฉด์—ญ ๋ฐ˜์‘์ด ์ œ๋Œ€๋กœ ์ž‘์šฉํ•˜์ง€ ์•Š์Œ.

๐ŸŸข Key Cellular Players

Macrophages, Lymphocytes, Fibroblasts 3๊ฐ€์ง€๋ฅผ ๊ธฐ์–ตํ•˜์ž. โ€œSequenceโ€๊ฐ€ ์•„๋‹ˆ๋ผ, ์„œ๋กœ์„œ๋กœ ์ž‘์šฉํ•จ.

Macrophage Activation : M1๊ณผ M2์˜ ์—ญํ•  ์ฐจ์ด

Classically Activated Macrophages (M1) : proinflammatory

  • โ€œ์ด‰์ง„โ€ํ•œ๋‹ค. ์ด๋ฌผ ์ œ๊ฑฐ, ๊ฐ์—ผ์„ฑ ์›์ธ์ฒด ์ œ๊ฑฐ๋ฅผ ์œ„ํ•œ proinflammatory ๋ฐ˜์‘.

Alternatively Activated Macrophages (M2) : anti-inflammatory

  • ์กฐ์ง ํšŒ๋ณต ๋‹จ๊ณ„์—์„œ ์ค‘์š”. ์—ผ์ฆ ๋ฐ˜์‘์„ โ€œ์–ต์ œโ€ํ•จ.
  • โ€˜M1โ€™์ด ์ฃผ๋„ํ•˜๋Š” ์—ผ์ฆ ๋ฐ˜์‘์„ ์–ต์ œํ•จ.
  • Fibrosis์™€ ๊ธด๋ฐ€ํ•œ ์—ฐ๊ด€ (fibroblast๋ฅผ ํ™œ์„ฑํ™”ํ•ด์„œ, collagen์ด ๋‚˜์™€์„œ ์†์ƒ ๋ถ€์œ„๋ฅผ ๋ฎ์–ด์ฃผ๊ฒŒ ํ•จ.)

โœ… Granulomatous Inflammation (์œก์•„์ข…์„ฑ ์—ผ์ฆ๋ฐ˜์‘)

Macrophage๊ฐ€ ์—ผ์ฆ ๊ตฌ๊ฐ„์„ ๋ฎ๊ณ  ์žˆ์„ ๋•Œ ํ™œ์„ฑํ™”๋œ๋‹ค. Macrophage๊ฐ€ ๊ทธ ๋ถ€์œ„์— ์••๋„์ ์œผ๋กœ ๋งŽ์œผ๋ฉด ์œก์•„์ข…์„ฑ!

  • Epithelloid Macrophage๊ฐ€ ๋งŽ์ด ๊ด€์ฐฐ๋œ๋‹ค.
    • Epithelloid Macrophages : ๋‹ค๋ฅธ ๋Œ€์‹์„ธํฌ์— ๋น„ํ•ด ๋” ๊ฐ์ง€๊ณ , ์ƒํ”ผ์„ธํฌ์ฒ˜๋Ÿผ ๋ชจ์—ฌ์žˆ๋Š” ์„ฑ์งˆ์ด ์žˆ๋‹ค.
  • Multinucleated Giant Cells : ํ•œ ์„ธํฌ์— ํ•ต์ด ๋งŽ๊ณ , ๊ทธ๋งŒํผ ์„ธํฌ๊ฐ€ ํฌ๋‹ค.

macrophages๊ฐ€ ๋ฉ€๋ฆฌ ์œ ์ถœ๋˜์ง€ ์•Š๋„๋ก ๊ฐ์‹ธ์„œ ๊ฐ€์ง€๊ณ  ์žˆ๋Š”์ƒํ™ฉ. granuloma๊ฐ€ ํผ์ ธ ์žˆ๋Š” ์ƒํƒœ๋ฅผ granulomatous inflammation

Nodular (Tuberculoid)Diffuse (Lepromatous)
์กฐ์งํ™”๋œ ๊ฒฐ์ ˆ ํ˜•ํƒœ, ๋ฆผํ”„๊ตฌ ํ…Œ๋‘๋ฆฌ + ์„ฌ์œ ์„ฑ ํ”ผ๋ง‰๊ฒฝ๊ณ„ ๋ถˆ๋ช…ํ™•, ๊ด‘๋ฒ”์œ„ํ•œ ๋Œ€์‹์„ธํฌ ์ธต, ๋ฆผํ”„๊ตฌ ์ ์Œ, ํ”ผ๋ง‰ ์—†์Œ
๊ฐ•ํ•œ Th1 ์„ธํฌ๋งค๊ฐœ ๋ฉด์—ญ์•ฝํ•œ ๋ฉด์—ญ ๋˜๋Š” Th2 ํŽธํ–ฅ ๋ฐ˜์‘
Mycobacterium bovis, ํŠน์ • ์ง„๊ท Johneโ€™s disease ๋“ฑ
์ค‘์‹ฌ์— ๊ฑด๋ฝ์„ฑ(caseous) ๊ดด์‚ฌ ๊ฐ€๋Šฅ๊ดด์‚ฌ ์—†์Œ ๋˜๋Š” ๋ฏธ์•ฝ
์ƒ๋Œ€์ ์œผ๋กœ ์ ์Œ๋ณ‘์›์ฒด ๋‹ค๋Ÿ‰ ์กด์žฌ

์ด๋ ‡๊ฒŒ ๋ณ‘๋ฆฌํ•™์ž๋Š” ์–ด๋–ค ํ˜•ํƒœ์˜ ์—ผ์ฆ์„ธํฌ์ธ์ง€ ํ™•์ธํ•˜๊ณ , ์—ผ์ฆ์„ธํฌ ์•ˆ์˜ ๊ฐ์—ผ์ฒด๋ฅผ ํ™•์ธํ•˜๋Š” ์ž‘์—…์„ ํ•ฉ๋‹ˆ๋‹ค~

โœ… Eosinophilic Granulomas

๊ณ ์–‘์ด์—์„œ ๋…ํŠนํ•˜๊ฒŒ ๋งŽ์ด ๊ด€์ฐฐ๋œ๋‹ค. ๊ณ ์–‘์ด๋Š” ํ”ผ๋ถ€, ๊ตฌ๊ฐ• ์ ๋ง‰ ๋“ฑ์— (์ ๋ง‰ํ•˜์ธต์—) eosinophils์ด ๊ต‰์žฅํžˆ ๋งŽ๋‹ค. (๊ฐœ์— ๋น„ํ•ด)

Macrophages & eosinophils ๋’ค์„ž์—ฌ ์žˆ์Œ.

Feline eosinophilic granuloma complex

  • ํ˜ธ์‚ฐ๊ตฌ์˜ ๋™์›์„ ๋ดค์„ ๋•Œ ๊ณผ๋ฏผ๋ฐ˜์‘/์•Œ๋Ÿฌ์ง€์— ์˜ํ•œ ๊ฒƒ.
  • ํ˜น์€ ๊ธฐ์ƒ์ถฉ ๋•Œ๋ฌธ์ผ ์ˆ˜๋„.

IL-4, IL-13์ด ๋™์›๋œ๋‹ค๊ณ  ํ•จ Th2-directed immune response์— ์˜ํ•œ ๊ฒƒ์œผ๋กœ ๋ณด์ž„

  • Type2 helper cell ํ˜•ํƒœํ•™์  ์ •์˜ > ์›์ธ ํŒŒ์•…!

5. ์—ผ์ฆ ๋ฐ˜์‘์˜ ๊ฒฐ๊ณผ & ํšŒ๋ณต

Minimal damageModest damageSustained damage
์ตœ์†Œํ•œ์˜ ์†์ƒ์ค‘๊ฐ„ ์ •๋„์˜ ์†์ƒ์ง€์†์ ์œผ๋กœ ๊ฐ€ํ•ด์ง€๋Š” ์ž๊ทน
or ๊ฐ€ํ•ด์ง„ ์ž๊ทน์ด ๊ณ„์† ๋‚จ์•„์žˆ์Œ
(ex. allergen์— ๊ณ„์† ๋…ธ์ถœ, ์ œ๊ฑฐ๋˜์ง€ ์•Š์€ ์ด๋ฌผ)
๋งŒ์„ฑ ์—ผ์ฆ or ๋†์–‘ ํ˜•์„ฑ

๐ŸŸข ๊ธ‰์„ฑ ์—ผ์ฆ ๋ฐ˜์‘์˜ 4๊ฐ€์ง€ ๊ฒฐ๊ณผ

  • Resolution : ๊ธ‰์„ฑ ์—ผ์ฆ ๋‹จ๊ณ„์—์„œ ํ•ด๊ฒฐ๋จ. ์™„์ „ํžˆ ์›์ƒ๋ณต๊ตฌ

  • Healing by Fibrosis : ์‹ค์งˆ์ ์ธ ์„ธํฌ๊ฐ€ ํšŒ๋ณต๋˜์ง€ ์•Š๊ณ  โ€˜์ƒ์ฒ˜(scar)โ€˜๋กœ ๋‚จ์•„์žˆ์Œ

  • Abscess Formation : ๋งŒ์„ฑ์œผ๋กœ ์ด์–ด์ ธ ๋†์–‘์ด ํ˜•์„ฑ๋จ / ๋Œ€์‹๊ตฌ๊ฐ€ ์ฃผ๊ฐ€ ๋จ

  • ๋งŒ์„ฑ ๋ฐ˜์‘์œผ๋กœ ์ด์–ด์ง.

  • Wound healing

      1. Hemostasis :
      1. Inflammation :
      1. Proliferation : ํ˜ˆ๊ด€, ๊ฒฐํ•ฉ์กฐ์ง์„ ๋งŒ๋“œ๋Š” ์ฆ์‹ / ์ƒํ”ผ์„ธํฌ๊ฐ€ ์™„์ „ํžˆ ๋‹ค์‹œ ์ž๋ผ๋‚˜๋Š” ์ฆ์‹
      1. Remodeling :
First Intention Healing
Pasted image 20250930120743.png
2) granulation tissue : fibroblast & ํ˜ˆ๊ด€ํ™”๊ฐ€ ๋งŽ์ด ์ง„ํ–‰๋œ ํ”ผ๋ถ€. ์—ฐํ•˜๊ณ  ๋ง๋ž‘๋ง๋ž‘. ํ˜ˆ๊ด€์ด ๊ณต๊ธ‰๋˜์–ด ์žˆ์–ด์•ผ ์˜์–‘์„ ๊ณต๊ธ‰๋ฐ›๊ณ  ์ฆ์‹ํ•  ์ˆ˜ ์žˆ์Œ. ๊ทธ๋ž˜์„œ ์ฆ์‹์—๋Š” โ€˜granulation tissueโ€™๊ฐ€ ๋ฐ˜๋“œ์‹œ ํ•„์š”ํ•จ.
์†์ƒ ๋ถ€์œ„๊ฐ€ ์ข์Œ. ๋‚ ๋ ตํ•˜๊ฒŒ ๋ฒ ์ด๊ฑฐ๋‚˜ ์†์ƒ. ์ƒํ”ผ์„ธํฌ๊ฐ€ ๋งŽ์ด ์†์ƒ๋˜์ง€ ์•Š์Œ.
โ†’ ์†์ƒ ๋ถ€์œ„๊ฐ€ ์ข์•„ ์ƒํ”ผ์„ธํฌ๊ฐ€ ๋ฉ”์šฐ๊ธฐ ์‰ฌ์›€. (migration ํ•ด์•ผ ํ•  ๊ฑฐ๋ฆฌ๊ฐ€ ์ข์Œ)
๋‹ค์‹œ ์›๋ž˜์ฒ˜๋Ÿผ ํ‰ํ‰ํ•˜๊ฒŒ ํšŒ๋ณต๋จ.
Second Intention Healing
Pasted image 20250930121014.png
์†์ƒ ๋ถ€์œ„๊ฐ€ ๋„“์–ด์„œ, retraction ํ•„์š”.
Fibrosis์˜ ์ˆ˜์ถ•์— ์˜ํ•ด ์ƒ์ฒ˜ ๋ถ€์œ„๊ฐ€ ์›€ํ‘น ๊บผ์ง.

๐ŸŸข Proliferation Phase

Granulation Tissue

(๋นจ๊ฐ„์ƒ‰ ๋‹จ์–ด ๊ผญ ๊ธฐ์–ต!)

  • Granular surface ๋•Œ๋ฌธ์— ์ด๋ ‡๊ฒŒ ๋ถˆ๋ฆผ.
  • (๋”ฑ์ง€๋ฅผ ๋—์„ ๋•Œ ์žˆ๋Š” ๋ถˆ๊ทธ์Šค๋ฆ„ํ•˜๊ณ  ์šธํ‰๋ถˆํ‰ํ•œ ํ”ผ๋ถ€)
  • ์†์ƒ์— ์ทจ์•ฝํ•จ.
  • ํ˜ˆ๊ด€์ด ๋งŽ์ด ์ƒ์„ฑ๋˜์–ด ์žˆ๊ธฐ ๋•Œ๋ฌธ์—, ๋‹ค์‹œ ๋‹ค์น˜๋ฉด ํ”ผ๊ฐ€ ๋” ๋งŽ์ด ๋‚จ.
  • ์ฝœ๋ผ๊ฒ์ด ๊ฑฐ์˜ ์—†๊ณ  ์„ธํฌ(fibroblasts, ๋ชจ์„ธํ˜ˆ๊ด€, endothelium)๋กœ๋งŒ ๊ตฌ์„ฑ๋จ.
  • ์™„์ „ํžˆ ์ž˜ ํšŒ๋ณต๋˜๋ฉด ๋”ฑ์ง€๋Š” ์ž์—ฐ์Šค๋ ˆ ๋–ผ์–ด์ง„๋‹ค.
  • ์ƒํ”ผ์„ธํฌ์˜ ์žฌ์ƒ (์‹ค์ œ ๊ธฐ๋Šฅํ•˜๋Š” ์„ธํฌ๋กœ ์žฌ์ƒ๋˜๋Š”) ์ด ์ค‘์š”ํ•œ ํ‚ค!
Angiogenesis
  • ์›๋ž˜ ์กด์žฌํ•˜๋Š” ํ˜ˆ๊ด€์œผ๋กœ๋ถ€ํ„ฐ ๋งŒ๋“ค์–ด์ง„๋‹ค.
  • ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ๋„ basement membrane์— ๋ถ™์–ด ์žˆ๋‹ค.
    1. basement memb.์ด ๊นจ์ ธ์„œ ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ๊ฐ€ ๋‚˜์˜ค๊ณ 
    1. ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ๊ฐ€ ํผ์ ธ๋‚˜๊ฐ
  • ์ƒˆ๋กœ์šด ๋‚ด๊ฐ•์„ ๋งŒ๋“ฆ
  • ๊ทธ ์ฃผ๋ณ€์„ ํ‰ํ™œ๊ทผ, pericytes๊ฐ€ ๋‘˜๋Ÿฌ์‹ธ๋ฉด์„œ ์™„์ „ํ•œ ํ˜ˆ๊ด€ ๊ตฌ์กฐ๊ฐ€ ๋งŒ๋“ค์–ด์ง„๋‹ค
  1. membrane ๊นจ์ง€๊ณ 
  2. ํ˜ˆ๊ด€๋‚ดํ”ผ์„ธํฌ ํผ์ ธ๋‚˜๊ฐ, ์ดˆ๋ฐ˜์— ๋‚˜์˜จ ์• ๋“ค์ด ์ด๋™ํ•ด์„œ ๊ธธ์„ ์žก์•„ ๋†“๊ณ 
  3. ๋”ฐ๋ผ์˜ค๋Š” ์„ธํฌ๋“ค์ด ์ฆ์‹ํ•˜๋ฉด์„œ ํ˜ˆ๊ด€์„ ์•ˆ์ •์ ์œผ๋กœ

๊ตฌ์กฐ๋ฅผ ๋จผ์ € ์žก์•„๋†“๊ณ  (๊ธธ) โ†’ ๊ธฐ๋Šฅ์ ์ธ ๋ถ€๋ถ„์ด ์™„์„ฑ๋จ (ํˆฌ๊ณผ์„ฑ)

Re-epithelialization (์žฌ์ƒํ”ผํ™”)

์†์ƒ ๋ถ€์œ„์˜ basement membrane์ด ๋ฉ€์ฉกํ•œ์ง€, ์†์ƒ๋˜์—ˆ๋Š”์ง€์— ๋”ฐ๋ผ ํšŒ๋ณต๋ ฅ์ด ๋‹ฌ๋ผ์ง. ์†์ƒ๋œ ๋ถ€์œ„์˜ ๊ฐ€์žฅ์ž๋ฆฌ๋กœ๋ถ€ํ„ฐ ์ƒˆ๋กœ์šด ์„ธํฌ๋“ค์ด ๋งŒ๋“ค์–ด์ ธ์„œ migration

๐ŸŸข Remodeling Phase

๊ตฌ์กฐ์ ์œผ๋กœ ์™„์ „ํ•ด์ง.

  • ๊ธฐ๋Šฅ์ ์œผ๋กœ ์™„์ „ํ•ด์งˆ ๊ฒƒ์ธ์ง€ (์™„์ „ํžˆ ํšŒ๋ณต)
  • ๊ธฐ๋Šฅ์€ ์ฑ„์›Œ์ง€์ง€ ์•Š๋Š”์ง€ (์„ธํฌ๊ฐ€ ์ฑ„์›Œ์ง€์ง€ ์•Š์•„ ๊ฒฐํ•ฉ์กฐ์ง์œผ๋กœ ๋Œ€์ฒด) ์†์ƒ๋œ ๋ถ€์œ„ : ์„ธํฌ๊ฐ€ ๋ณ„๋กœ ์—†๊ณ , ํ˜ˆ๊ด€๋„ ๋ณ„๋กœ ์—†์Œ (acellular, avascular) ์„ธํฌ๊ฐ€ ๋‹ค ํšŒ๋ณต๋˜์ง€ ๋ชปํ•ด์„œ ๊ฒฐํ•ฉ์กฐ์ง์œผ๋กœ ๋Œ€์ฒด๋œ ๊ฒƒ์ด โ€˜scarโ€™ > ํ˜ˆ๊ด€์ด ๋ฐœ๋‹ฌํ•˜์ง€ ์•Š์Œ.

Factors

  • Glucocorticoids (steroids) : ๊ด‘๋ฒ”์œ„ํ•œ ์ฐฝ์ƒ์— ์†Œ์—ผ์ œ๋ฅผ ์จ์•ผ ํ•˜๋Š”๋ฐ, ๊ณผ๋„ํ•œ ์†Œ์—ผ์ œ๋Š” ํšŒ๋ณต์„ ๋”๋””๊ฒŒ ํ•  ์ˆ˜ ์žˆ๋‹ค.

Abscess Formation

ํšŒ๋ณต๋˜์ง€ ์•Š๊ณ  ๋†์–‘์œผ๋กœ ๋‚จ์„ ๋•Œ

  • ํ˜ธ์ค‘๊ตฌ๋งŒ ๋งŽ์ด ๋‚จ์•„์žˆ์Œ
  • ํŠน์ • species๋งŒ ๊ณต๊ฒฉํ•˜๋Š” ๊ฒŒ ์•„๋‹ˆ๋ผ, ๋งŽ์ด ๋™์›๋œ ํ˜ธ์ค‘๊ตฌ๊ฐ€ ๊ดด์‚ฌ๋ฅผ ์‹ฌํ•˜๊ฒŒ ์ผ์œผ์ผœ์„œ
  • ๊ฐ€์šด๋ฐ ๋ถ€๋ถ„์— ํ˜ธ์ค‘๊ตฌ+์ฃฝ์€ ์„ธํฌ๋“ค์ด ์„ž์—ฌ ์žˆ๋Š” โ€˜๋†(pus)โ€™
  • ๊ทธ ์ฃผ๋ณ€์„ ๊ฒฐํ•ฉ์กฐ์ง์ด ๋‘˜๋Ÿฌ์Œˆ : โ€˜๋†์–‘โ€™
Types- Septic : ๊ฐ์—ผ์„ฑ ์›์ธ์ฒด
- Sterile : ์™ธ๋ถ€์—์„œ ์ฃผ์ž…๋œ ๊ฒƒ์— ์˜ํ•ด. ๊ทธ ์ฃผ๋ณ€์— ๋†์–‘์œผ๋กœ ๋ฎ์ผ ์ˆ˜ ์žˆ์Œ
- ํ™”๋†์„ฑ > ๊ธ‰์„ฑ
- ๋†์–‘ > ๊ฒฐํ•ฉ์กฐ์ง์ด ๋‘๊ป๊ฒŒ ๋‘˜๋Ÿฌ์Œˆ(fibrosis), ๋งŒ์„ฑ์— ํ•ด๋‹น

Scarring (Healing by Fibrosis)

  • ๋‘๊บผ์šด ๊ฒฐํ•ฉ์กฐ์ง์ด ๋นˆ ๋ถ€๋ถ„์„ ์ฑ„์›€.
  • ์›๋ž˜ ์žˆ๋˜ ์„ธํฌ๋“ค์ด ์—†๊ณ , ๊ตฌ์กฐ์ ์œผ๋กœ๋งŒ ๊ฒฐํ•ฉ์กฐ์ง์œผ๋กœ ๋Œ€์ฒด๋จ.

6. Systemic Effects

  • Septicemia : ์„ธ๊ท ์ด ์ „์‹ ์ ์œผ๋กœ ๋Œ์•„๋‹ค๋‹˜
  • ์›์ธ
    • ์„ธ๊ท  ๋ฉ์–ด๋ฆฌ๋‚˜, ์„ธ๊ท ์—์„œ ๋‚˜์˜จ toxin์ด ๋Œ์•„๋‹ค๋‹ˆ๋Š” ๊ฒƒ.
    • ์‹ ์ฒด ์–ด๋А ๋ถ€๋ถ„์—์„œ๋‚˜ ๋ฌธ์ œ๊ฐ€ ์ƒ๊ธธ ์ˆ˜ ์žˆ๋‹ค.
    • ํŠนํžˆ ๊ทธ๋žŒ์Œ์„ฑ๊ท ์˜ LPS๋Š” ํ˜ˆ๊ด€์„ ์†์ƒ์‹œ์ผœ DIC๋ฅผ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ์Œ,
    • ํ˜ˆ์•ก์ด ์ œ๋Œ€๋กœ ๊ณต๊ธ‰๋˜์ง€ ์•Š์•„ ๋‹ค์–‘ํ•œ ์žฅ๊ธฐ์— ๋™์‹œ๋‹ค๋ฐœ์ ์œผ๋กœ ์†์ƒ์„ ์ผ์œผํ‚ด > MOF (ํŠนํžˆ ํ ๊ฐ„ ์‹ฌ์žฅ ๋‡Œ) > ํ์‚ฌ

Morphologic Diagnosis

์–ด๋–ป๊ฒŒ ์ง„๋‹จ๋ช…์„ ๋‚˜ํƒ€๋‚ผ ์ˆ˜ ์žˆ์„๊นŒ? ์ด 6๊ฐ€์ง€ ๊ธฐ์ค€(DDDEMT)์œผ๋กœ ๋ชจ๋“  ์กฐ์งํ•™์  ์†Œ๊ฒฌ์„ ์ •๋ฆฌํ•ด์„œ ๋‚˜ํƒ€๋‚ผ ์ˆ˜ ์žˆ๋‹ค.

DDDEMT
Degree์ •๋„
Duration๊ธ‰์„ฑ/๋งŒ์„ฑ
Distribution๋ถ„ํฌ (์œก์•ˆ์ /์กฐ์งํ•™์ )
(Focal, multifocal, locally/focally extensive (๊ตญ์†Œ์ ์ด์ง€๋งŒ ๋„“๊ฒŒ), diffuse)
Exudate์—ผ์ฆ์„ ๊ตฌ์„ฑํ•˜๋Š” ์ข…๋ฅ˜
(์‚ผ์ถœ์„ฑ, ํ™”๋†์„ฑ, ์œก์•„์ข…์„ฑ)
Modifier๊ดด์‚ฌ์„ฑ, ์ถœํ˜ˆ์„ฑ (ํ”ํžˆ ๋ถ™์ด์ง€๋Š” ์•Š์Œ)
Tissue์–ด๋–ค ์žฅ๊ธฐ์— ์ƒ๊ธด ์—ผ์ฆ์ธ์ง€

5์ฃผ์ฐจ-2

์‚ฌ์ง„

  • serous : ์•ก์ฒด ์„ฑ๋ถ„๋งŒ ๋งŽ์Œ. ์—ผ์ฆ๋ฌผ์งˆ์ด ๋™์›๋˜๊ธฐ ์ „. ํ˜ˆ๊ด€ ๋ฐ˜์‘์—์„œ ์—ผ์ฆ ์„ธํฌ๋“ค์€ ๋™์›๋˜์ง€ ์•Š์€ ์ดˆ๊ธฐ ๋‹จ๊ณ„.
  • fibrinous : ์ด๊ฒƒ๋„ ๊ธ‰์„ฑ ๋ฐ˜์‘.
  • catarrhal (mucoid) : ์ ์•ก์„ฑ ์—ผ์ฆ. ์ ์•ก์„ธํฌ๊ฐ€ ์žˆ๋Š” ์žฅ๊ธฐ๋“ค์— ์กด์žฌ. ์ผ๋ถ€ ์—ผ์ฆ์„ธํฌ๋“ค์€ ใ…‡์ ์•ก์„ธํฌ์˜ ์ฆ์‹์„ ์œ ๋„ํ•จ. (ํŠน์ • ์—ผ์ฆ์ƒํ™ฉ์—์„œ) โ†’ ์ ์•ก์˜ ์–‘์ด ๋Š˜์–ด๋‚˜์„œ ๋ˆ์ ๋ˆ์ ํ•˜๊ณ  ์ ค๋ผํ‹ด ๊ฐ™์€ : ์—ผ์ฆ์„ธํฌ์˜ ์ข…๋ฅ˜๋ณด๋‹ค๋Š” ์ ์•ก์„ธํฌ์˜ ์ฆ๊ฐ€์™€ ์ ์•ก๋ถ„๋น„์˜ ์ฆ๊ฐ€๊ฐ€ ํ•ต์‹ฌ.
  • suppurative
  • ๊ฐ๊ฐ์˜ ๊ตฌ์„ฑ ์„ฑ๋ถ„์€ ์•Œ์•„๋†“์ž.

Fig.1 ์–‘์˜ ๊ด‘๊ณผ๋ฏผ์ฆ, ํ”ผ๋ถ€์—์„œ ๋ถ€์ข… ์†Œ๊ฒฌ์ด ๋ฐœ๊ฒฌ๋จ. ํ˜ˆ๊ด€์—์„œ fluid๊ฐ€ ๋น ์ ธ๋‚˜์˜จ ๊ฒƒ.

intralesional fungal hyphae(๊ธธ์ญ‰ํ•œ ํ˜•ํƒœ ๋ง‰๋Œ€๊ธฐ) > ์ด๋Ÿฐ ๊ฒŒ ๊ด€์ฐฐ๋˜๋ฉด โ€˜dermatophyticโ€™ ์ด๋ผ๊ณ  ๋ถ™์ผ ์ˆ˜ ์žˆ์Œ.

Summary